REGISTERED NUMBER: 04220156 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 October 2025

for

Mirabel Cosmetic Injections Limited

Page

Balance Sheet

1

FIXED ASSETS

96,339

100,072

CURRENT ASSETS

162,115

143,227

CREDITORS

Amounts falling due within one year

(28,563

)

(32,186

)

NET CURRENT ASSETS

133,552

111,041

TOTAL ASSETS LESS CURRENT LIABILITIES

229,891

211,113

CREDITORS

Amounts falling due after more than one year

-

(6,161

)

ACCRUALS AND DEFERRED INCOME

(3,498

)

(3,636

)

NET ASSETS

226,393

201,316

CAPITAL AND RESERVES

226,393

201,316

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Mirabel Cosmetic Injections Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

04220156

Registered office:

Southend House

Ogbourne St George

Marlborough

Wiltshire

SN8 1SG

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 6 (2024 - 6 ) .

3.	PRIOR YEAR ADJUSTMENT

During the preparation of the financial statements for the year ended 31 October 2025, it was noted that a pension contribution had been incorrectly accounted for as a dividend, resulting in an overstatement of corporation tax for the year ended 31 October 2024.

This has resulted in a decrease of the tax charge on the balance sheet to £nil and an increase in retained earnings of £19,286.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 29 June 2026 and were signed by:

Dr A C Brooks - Director